Author

V. Delmas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

I. Davidson· 2 shared L. Larue· 2 shared V. Petit· 2 shared Z. Aktary· 2 shared A. Bellacosa· 1 shared A. Berger· 1 shared A. Sarasin· 1 shared B. Vergier· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

I. Davidson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Functional expression of a Mo-dependent formate dehydrogenase in Escherichia coli under aerobic conditions

M. Schulz, A. Berger, I. Dubois, V. Delmas, M. Cadillon, M. Bouzon, V. Doring

The paper reports the functional expression of a Mo-dependent formate dehydrogenase in E. coli under aerobic conditions, showing growth on formate as sole energy source and identifying mutations in a formate transporter gene as key to adaptation.

bioRxiv · Oct 27, 2023 · PreprintBioengineering

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

J. H. Raymond, M. Schonau, V. Petit, Z. Aktary, F. Luciani, M. Wehbe, I. Davidson, C.-L. Tomasetto, F. Mahuteau-Betzer, B. Vergier, L. Larue, V. Delmas

This study identifies an E-cadherin-ER-GRPR axis that drives sex-specific melanoma metastasis and shows GRPR inhibition reduces metastasis in vivo.

bioRxiv · Dec 2, 2022 · PreprintCancer Biology

BRN2 is a non-canonical melanoma tumor-suppressor

M. Hamm, P. Sohier, V. Petit, J. Raymond, V. Delmas, M. Le Coz, F. Gesbert, C. Kenny, Z. Aktary, M. Pouteaux, F. Rambow, A. Sarasin, A. Bellacosa, L. Sanchez-del-Campo, L. Mosteo, , L. Larue

This study identifies BRN2 as a non-canonical tumor suppressor in melanoma, showing its role in initiation and progression through PTEN regulation and PI3K signaling.

bioRxiv · Jan 13, 2021Cancer Biology